|
ABI2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.94989999982675E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.98740000000508E-05 |
| Normal-vs-Stage2 |
4.518600E-03 |
| Normal-vs-Stage3 |
3.032200E-04 |
| Normal-vs-Stage4 |
1.105970E-01 |
| Stage1-vs-Stage2 |
6.712000E-01 |
| Stage1-vs-Stage3 |
4.815800E-01 |
| Stage1-vs-Stage4 |
9.632200E-01 |
| Stage2-vs-Stage3 |
9.626400E-01 |
| Stage2-vs-Stage4 |
6.936000E-01 |
| Stage3-vs-Stage4 |
6.287800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.72530000000604E-06 |
| Normal-vs-AfricanAmerican |
7.232200E-04 |
| Normal-vs-Asian |
1.595520E-04 |
| Caucasian-vs-AfricanAmerican |
9.800400E-01 |
| Caucasian-vs-Asian |
5.147200E-01 |
| AfricanAmerican-vs-Asian |
4.419000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39810052424139E-10 |
| Normal-vs-Female |
6.070800E-01 |
| Male-vs-Female |
3.417400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.41110000000133E-05 |
| Normal-vs-Extreme_Weight |
1.005380E-04 |
| Normal-vs-Obese |
4.795600E-03 |
| Normal-vs-Extreme_Obese |
6.117600E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.561600E-01 |
| Normal_Weight-vs-Obese |
1.922630E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.909200E-01 |
| Extreme_Weight-vs-Obese |
2.618800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.578200E-01 |
| Obese-vs-Extreme_Obese |
3.109600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.060550E-01 |
| Normal-vs-Age(41-60Yrs) |
2.579700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.1348999517935E-09 |
| Normal-vs-Age(81-100Yrs) |
1.652470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.598200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.806350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.118800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.340370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.231600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.890000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.81709999999402E-05 |
| Normal-VS-Type2 PRCC |
5.43232125949089E-13 |
| Normal-VS-KIRP CIMP |
7.904000E-01 |
| Normal-VS-Unclassified PRCC |
2.139000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.580730E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.725400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.166000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.260020E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.049740E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.360000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05959996332672E-09 |
| Normal-vs-N1 |
4.135800E-01 |
| Normal-vs-N2 |
2.191800E-01 |
| N0-vs-N1 |
1.589650E-02 |
| N0-vs-N2 |
1.382380E-01 |
| N1-vs-N2 |
9.025000E-01 |
|
|
